Affordable Access

deepdyve-link
Publisher Website

Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection.

Authors
  • Sugimoto, Ryosuke1
  • Iwasa, Motoh1
  • Hara, Nagisa2
  • Tamai, Yasuyuki1
  • Yoshikawa, Kyoko1
  • Ogura, Suguru1
  • Tanaka, Hideaki1
  • Eguchi, Akiko1
  • Yamamoto, Norihiko1
  • Kobayashi, Yoshinao1
  • Hasegawa, Hiroshi1
  • Takei, Yoshiyuki1
  • 1 Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan. , (Japan)
  • 2 Nutrition Unit, Mie University Hospital, Tsu, Japan. , (Japan)
Type
Published Article
Journal
Hepatology research : the official journal of the Japan Society of Hepatology
Publication Date
Nov 08, 2017
Identifiers
DOI: 10.1111/hepr.12999
PMID: 29115717
Source
Medline
Keywords
License
Unknown

Abstract

We continuously measured body composition in HCV infected patients who received DAA therapy and found that skeletal muscle mass was significantly increased, associated with an elevation of serum Alb levels and/or body weight or reduction in VFA, but only in patients who presented with LSM before DAA therapy.

Report this publication

Statistics

Seen <100 times